Background {#Sec1}
==========

Systematic reviews are considered the best way to synthesize evidence. This kind of review is developed with robust methodology to ensure that the review is reproducible. In contrast, narrative reviews do not include any pre-defined methodology or structure, which renders the reproduction of different steps challenging or impossible. One can argue that a narrative review may be inherently biased and therefore should not be viewed as a scientific work. What is the usefulness of research that cannot be reproduced? This rationale may be in line with recent efforts to prevent the wasteful use of research-related resources \[[@CR1]\].

Evidence suggests that narrative reviews are frequently cited in specific medical disciplines such as dentistry \[[@CR2]--[@CR4]\]. This study sought to evaluate the proportion and characteristics of narrative and systematic reviews in major medical journals. These journals are well regarded by both researchers and clinicians who use information from these journals for their research and clinical decision-making. The aim of this study was to elucidate the current practice of these journals in publishing systematic and non-systematic evidence in the form of reviews.

Therefore, we scrutinized the five highest-ranked general medical journals (as classified by impact factor (IF) since 2015 in the annual Journal Citation Report (JCR) published by Thomson Reuters) for narrative or systematic reviews. We also evaluated the association between number of citations of the selected articles or journal IF and type of review.

Methods {#Sec2}
=======

Eligibility criteria {#Sec3}
--------------------

Systematic and narrative reviews that focused on the management of diseases and had been published in one of five major medical journals were selected for analysis. These journals were chosen because we believe they publish a higher proportion of studies/reviews with scientific merit and clinical relevance. Reviews on other topics such as methodological issues and statistics were excluded. Analysis and commentary documents were also excluded. The medical journals searched were: *The New England Journal of Medicine* (*NEJM*; IF:59.558), *The Lancet (Lancet)* (IF:44.002), *The Journal of the American Medical Association* (*JAMA*) (IF:37.684), *The British Medical Journal* (*BMJ*) (IF:19.697), and *Annals of Internal Medicine* (*AIM*) (IF:16.593). We also categorized reviews with a population health or policy-making (PHPM) perspective.

Types of reviews: Definitions {#Sec4}
-----------------------------

Reviews in this study were classified as one of three types:

*Systematic review*: We considered a review "systematic" when authors explicitly reported the intention to perform a systematic review in the title, abstract or any part of the text.

*Narrative review with some methodology reported (narrative review-SMR)*: Authors report some steps that might be reproducible (e.g., data search and selection). The inclusion of search strategy and selection criteria is a requirement for publishing reviews in some journals \[[@CR5], [@CR6]\].

*Narrative review*: No report of the methodology used to perform the review (e.g., procedures for data search and selection). No part of the review can be reproduced.

Search strategy {#Sec5}
---------------

We obtained the International Standard Serial Numbers (ISSN) of the journals from the National Library of Medicine (NLM). The ISSN facilitates a focused and precise search. The ISSN numbers were: 0028--4793 for *NEJM*, 0140--6736 for *Lancet*, 0098--7484 for *JAMA*, 0959--8138 for *BMJ*, and 0003--4819 for *AIM*. A structured literature search was performed in MEDLINE via PubMed using a combination of ISSN numbers and the following keywords: *therapeutics OR therapeutic OR therapy OR therapies OR treatment OR treatments*. Finally, we applied the following PubMed filters: "review", "systematic reviews", and "custom date range (01 June 2015 to 01 June 2016)".

Data selection and extraction {#Sec6}
-----------------------------

Two authors (CMF, JW) independently selected the reviews by strictly following the pre-determined eligibility criteria. Two authors (CMF, NB) independently extracted information using a data extraction sheet developed by the first author that related to the following variables: 1) number of citations in Google Scholar received by different types of reviews (citations retrieved in the period between 23 and 27 August 2017); 2) number and proportion of different types of reviews published in the five medical journals included in this sample. We organized the reviews in two types (regarding their purpose): 1) clinically oriented (CO): reviews related to a clinical research question; 2) population health or policy making oriented (PHPM): reviews with a population perspective or more focused on the discussion of relevant topics. We used the following criteria to organize the reporting of methodology in the reviews: search strategy, data selection, data extraction, and quality/risk of bias (ROB) of primary studies included in the reviews. Disagreements on data selection and extraction procedures were resolved by discussion until consensus was achieved.

Data analysis {#Sec7}
-------------

We reported the distribution of reviews across the five medical journals and characteristics regarding type of review (narrative, systematic, or narrative review-SMR), the number of citations received (median and range), and IF (median and range). We checked types of reviews published in the five medical journals (which have different IF) and calculated the average IF (from 2015). After fitting a multinomial logistic regression model, we calculated risk ratios (RR) for dichotomous outcomes with respective 95% confidence intervals (CI). For this calculation, we grouped narrative reviews and narrative reviews-SMR into one group (narrative\*). Furthermore, the associations were investigated inversely, using linear regression with type of review (narrative\* = 1, systematic = 0) as predictor, and the number of citations and journal impact factor as dependent variables. Given that the predictor is dichotomous, the chi^2^ test was utilized (instead of the *p*-value) as significance measure. All data analysis was performed with MATLAB version R2016b (MathWorks Inc., Natick, Massachusetts).

Results {#Sec8}
=======

Our initial search yielded 372,245 documents. After use of the PubMed filters, 399 of these were selected. After independent scrutiny of the titles and abstracts, we excluded an additional 124 documents because they failed to meet the methodological definition of a systematic, narrative review-SMR, or narrative review (list of excluded articles with reasons for exclusion in the Additional file [1](#MOESM1){ref-type="media"}). A total of 275 reviews were ultimately included. The full list of articles included in this study is reported in the Additional file [2](#MOESM2){ref-type="media"}.

Table [1](#Tab1){ref-type="table"} and Fig. [1](#Fig1){ref-type="fig"} report the distribution of reviews across the five medical journals examined. Most reviews were CO narrative reviews-SMR (*N* = 117, 43%), followed by CO systematic reviews (*N* = 73, 26%), CO narrative reviews (*N* = 51, 19%), PHPM narrative reviews (*N* = 23, 8%), PHPM narrative reviews-SMR (*N* = 9, 3%), and PHPM systematic reviews (N = 2, 1%). *Lancet* contributed the most reviews (*N* = 118, 43%). *JAMA* contributed the fewest reviews (*N* = 25, 9%). *Lancet* published the most CO narrative reviews-SMR (*N* = 70, 25%), and *NEJM* published the most CO narrative reviews (*N* = 30, 11%). *NEJM* contributed only narrative reviews to the present sample. Figure [2](#Fig2){ref-type="fig"} reports the percentage of the different types of reviews (narrative\* and systematic) published in each of the five journals. Narrative\* reviews include narrative reviews plus narrative reviews-SMR. Table [2](#Tab2){ref-type="table"} presents the characteristics of narrative\* and systematic reviews. Following the pre-defined evaluation criteria, 126 narrative reviews (63%) of this sample reported information on how authors performed the search of literature.Table 1Distribution of reviews across the five medical journals. Numbers in parentheses are percentagesJournalTypes of reviewCO-NarrativeCO-Narrative with some method.CO-SystematicPHPM-NarrativePHPM-Narrative with some method.PHPM-SystematicThe New England Journal of Medicine30 (100)00000The Lancet6 (5)70 (59)12 (10)23 (20)6 (5)1 (1)The Journal of the American Medical Association1 (4)9 (36)14 (56)01 (4)0The BMJ8 (12)36 (54)19 (29)02 (3)1 (2)Annals of Internal Medicine6 (17)2 (6)28 (77)000*CO* clinically oriented, *PHPM* population health/policy-makingNarrative with some method. Means that the narrative reviews in this sample met one of the criterion (search strategy) that is potentially reproducible Fig. 1Distribution of types of reviews in the five medical journals (clinically oriented and population health/policy-making reviews presented together) Fig. 2Percentage of reviews (systematic and narrative\* (narrative reviews plus narrative reviews-SMR) in the five medical journals) Table 2Characteristics of reviews included in this study. Numbers in parenthesis are percentagesCharacteristicsSystematic reviewNarrative reviewClinically oriented (CO) issue^a^73 (97)168 (84)PHPM^b^ issue2 (3)32 (16)Number of citations546110,000Methodology reported?• Search4 (5)126 (63)• Selection0 (0)0 (0)• Extraction0 (0)0 (0)• Quality assessment0 (0)0 (0)• Search + selection0 (0)0 (0)• Search + quality assessment1 (1.5)0 (0)• Search + selection + extraction3 (4)0 (0)• Search + selection + quality assessment4 (5)0 (0)• Search + extraction + quality assessment1 (1.5)0 (0)• Search + selection + extraction + quality assessment60 (80)0 (0)• No methodology reported2 (3)74 (37)^a^CO issue: any review intended to address the management of a clinical condition (including also any measure to prevent disease). It includes reviews analysing the effectiveness, side-effects of interventions or both, effectiveness of screening etc^b^PHPM issue: any review intended to generate hypotheses or facilitate discussion in the medical community

The median number of citations was 45 (range = 2 to 311), 29.5 (range = 0 to 215), and 43 (range 9 to 388) for narrative, narrative reviews-SMR, and systematic reviews, respectively. The median number of citations for narrative\* reviews was 35 (range 0 to 311). The median IF was 44 (range 17 to 60), 44 (range 17 to 44), and 20 (range 17 to 44) for narrative, narrative reviews-SMR, and systematic reviews, respectively.

Logistic regression analysis generated a RR for the citations of 0.985 (95% CI 0.978 to 0.991) and for the IF 1.114 (95% CI 1.080 to 1.149). The coefficient for the citations regression was −18.17 (*p* = 0.0308) and for IF 13.19 (*p* \< 0.001).

Discussion {#Sec9}
==========

The present findings suggest that highly ranked medical journals publish more narrative reviews than systematic reviews. In this sample of reviews, the majority of reviews addressing clinical questions are narrative or narrative reviews-SMR. Compared with systematic reviews, narrative and narrative reviews-SMR are more likely to be published in highly ranked medical journals with higher IF. Systematic reviews, however, receive more citations than narrative and narrative reviews-SMR.

In one study \[[@CR7]\] that evaluated the publication of systematic reviews in orthopaedic journals, the authors hypothesized that the number of citations for systematic reviews published in leading orthopaedic journals would be greater than the number of citations for narrative reviews published in the same journal. The authors found that "rigorous" (in their evaluation) systematic reviews received more citations than non-rigorous systematic and narrative reviews. Another study \[[@CR8]\] evaluated five journals that published the most systematic reviews among a sample of 170 clinical journals in various medical fields. The authors found that systematic reviews were cited more often than narrative reviews. Similar results were found in a meta-analysis \[[@CR9]\] that determined which among a large sample of articles received the greatest number of citations (*N* = 2646). In that study, narrative reviews received fewer citations than other types of reviews. Our findings are in agreement with publications above, although some other studies report the opposite. For example, in the field of dentistry some studies revealed more numerous citations for narrative reviews in comparison to systematic reviews \[[@CR2]--[@CR4]\]. These findings are supported by another study published in the field of dermatology \[[@CR10]\] that found that authors of clinical trials and narrative reviews do not frequently cite systematic reviews. Some methodological \[[@CR11]\] and discipline related issues might explain this variability on the association type of review and number of citations.

The present results demonstrate that much information reported in reviews published in these five journals derives from potentially biased evidence. One might argue that all types of information are subject to bias, including studies with well-recognized methodology, such as systematic reviews. However, because these studies have a defined structure, they are vulnerable to audit and quality evaluation. For example, tools such as A Measurement Tool to Assess Systematic Reviews (AMSTAR) \[[@CR12]\] and a tool to assess risk of bias in systematic reviews (ROBIS) \[[@CR13]\] can be used to evaluate the methodological quality and risk of bias of systematic review domains. In contrast, narrative reviews do not allow for this type of evaluation because they do not have a structured framework. Therefore, evaluating the methodology and quality of narrative reviews is challenging, if not impossible. Our results are in fact an optimistic view of reality, taking into account that other types of articles (commentaries, opinion paper etc. which are not systematic) were not included in our analysis. Thus, we might have an even worst scenario on the evidence currently used to support clinical decisions.

The present study included a group of narrative reviews-SMR in order to differentiate studies with partially reproducible methodology from those without any reproducible methodology, i.e. narrative reviews. We understand this is the fairest judgement of articles that, at least, explicitly reported part of the methodology. Based on our evaluation criteria, these narrative reviews-SMR described the search strategy used in their reviews. In fact, most articles in this group come from *Lancet* and *BMJ* journals, where sections in the paper are entitled "search strategy and selection criteria" (*Lancet*) and "sources and selection criteria" (*BMJ*). The selection criteria section in these articles, however, does not seem to be reported in enough detail for repeatability and traceability \[[@CR14]\]. Nevertheless, these reviews do not allow for the complete reproduction of several steps and may therefore be considered as narrative reviews based on non-systematic evidence.

In our study, narrative\* reviews were more frequently published in journals with higher IF, as demonstrated by the regression coefficients. Furthermore, the reported RR indicates that the probability of a review being narrative\* (compared to the probability of being systematic) increases 1.114 times for each unit increase in the journal IF. This outcome likely reflects the fact that all publications in the journal with the highest IF (*NEJM*) were narrative reviews. These findings are in agreement with outcomes in other medical fields, such as dentistry and oncology, in which journals with the highest IF \[[@CR15], [@CR16]\] tend to publish invited narrative reviews. Based on this information, we postulate that readers may not be aware of the importance of the methodology of reviews in such highly ranked journals. For readers, publication in a highly ranked journal might be sufficient to confirm the quality of the article. It is, however, important to emphasize that narrative reviews published in such high-level medical journals are authored by specialists in their fields. Thus, it is likely that the work will be high-quality. The articles in these journals must pass a strict and rigid peer-review process \[[@CR17]\], a process that supports the delivery of reliable work. Furthermore, publishing in one of these journals is quite difficult. These journals have low acceptance rates, and some evidence suggests that low rates of manuscript acceptance appear to predict higher methodological quality scores \[[@CR18]\]. Thus, one can consider high IF as a proxy for quality. Nevertheless, these are arguments based on the backgrounds of people and journals involved in the process, rather than facts that can be measured, verified and replicated \[[@CR19]\]. A study's quality should be determined on its own merits rather than on the background and quality of its authors.

The present article does not recommend the total elimination of narrative reviews. These types of reviews have a place in science, but they should not be the first option for scientists seeking information to address clinical questions. Narrative reviews could be used to facilitate discussion of relevant topics. Because of its lack of structure (and consequent invulnerability to audit), a narrative review should not be used as the basis for any strategy (therapeutic or otherwise) to address human disease. High-quality medical journals could implement a policy of limiting the space devoted to "non-systematic" literature. Information serving as the basis for further research or decision-making should be published only when a systematic and reproducible approach was used. This approach would help to prevent research based on biased information. Because the focus of our study was on reviews on interventions, we also organised the reviews on CO and PHPM. The idea was to provide the reader with a better picture when the focus of the review is to facilitate discussion, (PHPM) or to address management of diseases (CO). We understand that a review focusing on the management of diseases require a more systematic approach to avoid or to reduce the chances of biased results.

Some limitations of the present study should be discussed. Firstly, the study included a select group of medical journals. One can consider this information being representative to these five journals only. However, the literature search in only these five medical journals was the main inclusion criterion in our study, and it might be considered a "strength" due to the potential impact of the present findings on the research and medical community. As commented above, these journals are considered the best medical journals available, as indicated by their very high IF. Researchers will very likely use studies reported in these journals to plan and perform their own research. Similarly, clinicians will use the evidence reported in these journals to support their decisions on therapeutic approaches. Secondly, we conducted the literature search over a relatively short period of one year. Hence, we cannot extrapolate the findings to older reviews. However, there is no reason to believe that the pattern of publication of narrative, narrative reviews-SMR and systematic reviews has changed over time. Because the systematic review was developed more recently than the narrative review, one would expect these journals to have published a greater proportion of narrative reviews in earlier years. Furthermore, with the rise of evidence-based medicine in recent years, researchers and clinicians should be more aware of the importance of methodology. Such an awareness might result in a greater proportion of systematic reviews.

The present study also intends to encourage discussion on a global definition for systematic reviews. We used a definition based on the intention of authors to perform a systematic review, instead of definitions published in the literature \[[@CR14], [@CR20], [@CR21]\] (see Additional file [3](#MOESM3){ref-type="media"}, systematic review definitions) which are all based on the perspectives of authors evaluating systematic reviews.

The main problem in defining systematic reviews is to determine thresholds for what is systematic and what is not. For example, two definitions \[[@CR14], [@CR20]\] report "reproducibility" as key characteristics of a systematic review. If this criterion is applied, many systematic reviews included in overviews would probably not be considered systematic. A recent publication showed that the information necessary to reproduce meta-analytic estimates was reported in only 65% of systematic reviews of biomedical interventions \[[@CR22]\]. Many overviews of systematic reviews demonstrated that there is poor reporting of systematic reviews in different medical disciplines when the PRISMA checklist is applied \[[@CR23]--[@CR26]\]. Thus, this poor reporting would limit (or even make impossible) the reproducibility of the methodology, and this criterion would not be met for selecting the review as systematic. Furthermore, we understand that judging the review from the intention of authors to perform a systematic review leads to a more fair evaluation. One can argue that authors not explicitly reporting a systematic review would have an unfair judgement when quality tools are applied. For example, if authors of the review intend to publish a narrative review, but authors of the overview considered it as a systematic review. Hence, a narrative review would be judged as systematic. Finally, by including reviews with poor or no methodology, but named as systematic by review authors, clinicians and non-methodologist readers will have more comprehensive information to differentiate the robust from the methodologically poor systematic reviews. This information would then be provided in the quality/ROB evaluation of reviews with available methodological tools \[[@CR12], [@CR13]\].

A previous study \[[@CR8]\] also compared systematic and narrative reviews in medical literature. They defined a review as systematic when "the authors had to clearly state the clinical topic of the review, how the evidence was retrieved and from what sources (i.e., naming the databases), and provide explicit inclusion and exclusion criteria." Thus, these criteria would meet the criteria for defining a narrative review-SMR in our sample. One may consider that some reviews regarded as systematic by Montori et al. \[[@CR8]\] could be, in fact, narrative reviews. We provided an analysis of narrative and systematic reviews (Table [2](#Tab2){ref-type="table"}) to report to what extent systematic reviews are in fact systematic, by applying some criteria reported in published systematic review definitions.

Conclusions {#Sec10}
===========

The present study demonstrated that narrative reviews are more prevalent than systematic reviews in highly ranked medical journals. Much of the evidence provided by these journals does not represent reproducible findings. We recommend that, to address clinical research questions, these journals consider publishing systematic evidence exclusively. Editors of medical journals should limit the amount of non-systematic evidence to reduce the probability of delivering biased information to readers. Further discussion on a consensus definition for systematic reviews is needed.
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